Article info
PDFHepatology
Original research
miR-541 potentiates the response of human hepatocellular carcinoma to sorafenib treatment by inhibiting autophagy
- Correspondence to Professor Wei-Fen Xie, Department of Gastroenterology, Changzheng Hospital, Second Military Medical University, Shanghai 20003, China; weifenxie{at}medmail.com.cn; Professor Xin Zhang, Department of Gastroenterology, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China; zhang68{at}hotmail.com; Professor Bin Lu, Department of Biochemical Pharmacy, School of Pharmacy, Second Military Medical University, Shanghai 200433, China; binlu{at}smmu.edu.cn
Citation
miR-541 potentiates the response of human hepatocellular carcinoma to sorafenib treatment by inhibiting autophagy
Publication history
- Received April 2, 2019
- Revised October 15, 2019
- Accepted October 23, 2019
- First published November 14, 2019.
Online issue publication
July 13, 2020
Article Versions
- Previous version (6 June 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.